The highest price is not the only form of value
Nvidia's position can be read strategically as success at a central bottleneck of the AI age: computing power. Wherever more complex models and applications arise, the infrastructure for them becomes decisive. The guiding question of this report goes a step further: What could happen if the next decisive bottleneck is resilience? This is not about the current size of another company, but about the category of a future problem.
Market value here denotes market capitalization: the price of a share multiplied by the number of outstanding shares at a given point in time. Future economic value means the prospect of later earnings. It depends on demand, execution, competitive advantages, rights, financing, and risks. Societal value, on the other hand, describes a contribution to quality of life, reliable information, security, and responsible coexistence. [Q01]
These levels can be connected, but they are not interchangeable. The strategic task consists of translating societal need into reliable services that others actually use and pay for. Not the size of a narrative, but the significance of the solved problem connects the future concept with economic value.
Why Nvidia is the economic benchmark today
Stock Analysis indicates for Nvidia as of October 7, 2026, around 5.73 trillion US dollars in market capitalization and the number one spot worldwide. That is a dated stock market standing, not a real-time display. The number describes a valuation by the stock market; it is neither revenue nor available cash. A later price level would have to be newly documented with its own source and its own date. [Q01]
The operational magnitude can be shown separately: Nvidia reported 215.9 billion US dollars in revenue for fiscal year 2026, which ended on January 25, 2026. In the more recent second quarter of fiscal year 2027, closed on July 26, 2026, revenue was 96.2 billion US dollars. The first amount covers a fiscal year, the second a quarter. Fiscal year designations are not to be equated with calendar years. [Q02] [Q03]
Nvidia's significance arises from the interplay of accelerated computing, hardware, the CUDA/software platform, and a broad developer ecosystem. The well-known shovels-in-the-gold-rush analogy captures part of this: infrastructure can be involved in many different applications. However, it underestimates the role of software, tools, and knowledge that actually make such an infrastructure usable. [Q02] [Q03]
Responsible usage is also no foreign topic for Nvidia. With NeMo Guardrails, the company itself offers an open-source Python tool for configurable testing and protection mechanisms in AI applications. It can check, block, or modify inputs and outputs based on established rules. A connection to COP CODE is not claimed here. [Q04]
A 1:1 against a weak comparison partner would be uninteresting. The benchmark is deliberately the strongest available: Nvidia leads the documented stock market comparison and combines extraordinary economic scale with comprehensive technological infrastructure. [Q01] [Q02] [Q03]
After computing power comes the question: What do we use it for?
Nvidia solves a fundamental problem: computers should be able to execute increasingly complex calculations ever faster. With growing computing power, however, the bottleneck can shift. What becomes technically possible must prove itself in life, in information, and in human action. [Q02] [Q03]
A system can generate enormous amounts of plausible information and still reach false conclusions. It can calculate a formally optimal decision whose human consequences are not acceptable. And biological performance remains bound to vulnerable human bodies despite digital progress. More speed alone does not answer these questions.
More power does not automatically solve the problem of resilience.
This is where the editorial thesis starts: biological resilience, informational resilience, and conflict-related resilience could become decisive prerequisites for a more powerful world. OM24®, AELTERMANN®, and COP CODE work on different subjects; their connection lies in this common design question.
Nvidia builds the infrastructure for systems to be more capable. The German-Swiss approach examined here poses the supplementary question of how systems remain reliable under growing power.
What the logic of God could have to do with corporate value
The philosophical foundation lies in the existing report "Can God be thought of as logic?". "God as logic" denotes there a model of a possible ultimate logic of order, truth, and meaning. It does not equate God with a computer program. Just as little do human dignity or the protection of life arise automatically from a mathematical formula. Ethical standards are explicitly set and must be justified. [Q10] Can God be thought of as logic?
For entrepreneurial action, this becomes a demanding test: Do statements agree with their evidence? What consequences do decisions have for people? Are mistakes corrected? Is short-term profit bought with later damages? Can success emerge without unnecessarily humiliating or harming others? Such questions take economic performance seriously but supplement it with responsibility.
The connection to AI is: A system should not just answer convincingly, but should comprehensibly consider its information basis and possible consequences. For companies, the corresponding task applies: to make one's own contribution and one's own interests verifiable. This is not a finished evaluation algorithm. It is an disclosed orientation for decisions, communication, and later technical testing.
In this model of thought, a company would not be special because it calls itself divine. Special would be the claim to allow oneself to be measured by truth, responsibility, and the protection of life, even when a more convenient story would sell better.
The potentially divine would not be a product feature. It would be the requirement for the order of the system.
Truth. Protection of life. Dignity. Responsibility. Functionality under stress.
Therefore, the AELTERMANN test does not contradict the grand claim. It is its consequence.
Resilience: What should remain intact under stress
Resilience here means the ability to remain functional under stress. This can mean something different for a cell, an information basis, or a decision process, respectively. The intellectual connection lies in shaping the conditions of reliability while performance increases.
OM24®
Biological resilience
How does a biological system remain functional under stress?
AELTERMANN®
Informational resilience
How does information remain verifiable when the number of plausible statements explodes?
COP CODE
Conflict resilience
How does intelligent decision-making remain constructive when conflict pressure increases?
Three levels. One common question: What prevents collapse under stress?
This connection is a structural analogy between different systems and not a mutual proof of effectiveness. The scientific and methodological foundations retain their own standards:
OM24®: Foundations and statement boundaries
OM24® is a defined active ingredient complex from Camellia sinensis and the subject of documented OMNIMEDICA research. The ETH Alumni page describes Omnimedica as an ETH spin-off. This proves the published origin reference, not every product promise or the status of every current legal entity. [Q05] [Q07]
A concrete scientific anchor is Mnich et al., published online in 2008 and in the journal year 2009. An OM24-containing lotion was compared with a placebo lotion on UVB-stressed human skin. Certain cellular damage markers were reduced, particularly p53-positive and apoptotic keratinocytes. For skin redness and thymine dimers, the study found no significant reduction. [Q06]
This finding applies to the examined topical application and its endpoints. It proves neither general life extension nor the effect of every orally ingested product. For further data, the research overview serves as a path to the original sources. Here, a concrete active ingredient, applications, and a verifiable research history exist. Economic potential depends on the respective evidence of benefit and successful marketing. [Q07]
AELTERMANN®: Foundations and statement boundaries
AELTERMANN®/ABEL.TV assigns statements to specific sources. Origin, interests, proof status, and statement boundaries become visible; changes and corrections remain traceable. The source register and verification matrix also demonstrate this working method in this report. In this process, the documentation itself is not converted into independent confirmation through repeated linking. [Q11] [Q14]
A claim graph denotes a structured connection between statements, entities, and sources. The registers visible here editorially depict such relationships. It is not claimed that a generally usable external claim graph API or a fully automated truth check is available. Further integration functions remain development prospects as long as their actual provision is not documented.
The strength lies in organizing information in a verifiable and correctable manner, not in claiming to be an infallible judge of truth. To this end, traceable research, clear assignment, and reliable maintenance are brought together. Whether customers or other systems derive measurably better decisions from this is a separate question of utility.
COP CODE: Fundamentals and statement boundaries
COP CODE is a published rule-based and development approach. The public repository contains a conceptual Python prototype under the MIT license. The README describes it as a verification and de-escalation layer for conflict-related AI outputs; it does not replace a language model, courts, mediation, or human judgment. [Q08] [Q09]
Dignity first. Do not sacrifice truth. Peace without humiliation. Justice without annihilation.
The approach aims to make harmful escalations visible and support better deliberation. Whether concrete implementations reliably achieve these goals must be tested using suitable comparative tests. A public codebase documents a stage of development; it is neither an independent effectiveness test nor proof of having solved the entire AI alignment problem.
Why 1:1?
Because this does not compare two stock market values, but two infrastructure tasks. Nvidia answers one of the big questions of the AI era: How do we get enough computing power?
The German-Swiss approach addresses a second one: How do biological systems, information, and decisions remain functional under growing stress? OM24®, AELTERMANN®, and COP CODE combine these three levels into a common strategic guiding idea.
Computing power without resilience is incomplete. Resilience without computing power does not solve technical scaling.
In this strategic comparison, the editorial result is therefore: USA – Germany/Switzerland: 1:1.
The benchmark is the importance of both tasks for a future shaped by AI. The comparison shows what each side contributes and on which scientific, economic, or technical foundations it is built. The different stages of development become visible and form the starting point of the development plan.
| Dimension | Nvidia (USA) | OMNIMEDICA, ABEL.TV, COP CODE (Germany/Switzerland) |
|---|---|---|
| Economic status [Q01] [Q02] [Q03] [Q14] [Q15] | 5.73 trillion US dollars market capitalization as of October 7, 2026; documented annual and quarterly revenues. | Separate companies and projects; no comparable joint company valuation. |
| Key contribution [Q02] [Q07] [Q08] [Q11] | Accelerated computing with hardware, software, and developer ecosystem. | Studying biological resilience, structuring information, and developing conflict management. |
| Software and protective mechanisms [Q04] [Q09] [Q11] | NeMo Guardrails: open-source, configurable verification mechanisms. | COP CODE: conceptual Python prototype; source register and methodology at AELTERMANN. |
| Research and development status [Q02] [Q04] [Q06] [Q09] [Q11] | Economically deployed infrastructure; official operational and software documentation. | Application-related OM24 study, editorial practice, and open development project; varying evidence. |
| Prerequisites for further growth | Further demand, implementation, competition, and responsible operation. | Proven added value, independent adoption, and sustainable revenue. |
A connection is not yet a corporation
OMNIMEDICA Group AG and OMNIMEDICA Deutschland GmbH are separate legal entities. OM24® is the active ingredient and subject of usage rights, not a collective name for these companies. Abel.TV Handels GmbH operates the source platform. AELTERMANN® is a brand and methodology; COP CODE is an independent project with published code. [Q07] [Q11] [Q14] [Q15]
The DPMA register information lists the word mark Aeltermann with register number 302025112508 and OMNIMEDICA Deutschland GmbH as the holder. The registration date is August 21, 2025; the information was checked on October 8, 2026. The methodology page describes the use by ABEL.TV as license-based. The register entry confirms the brand assignment, not the unpublished content of a license agreement. [Q11] [Q16]
The earlier research history of Omnimedica is not the founding date of today's Group AG. The official register extract of the Canton of Zurich confirms the registration on November 18, 2022, and publication in the SHAB on November 23, 2022. This directly checked original document confirms the current legal entity, not the beginning of all earlier research. Current participation quotas or a company valuation do not follow from this. [Q14] [Q15] [Q17]
The report therefore examines a strategic connection, not a proven overall group. A financial valuation would have to be carried out for clearly designated legal entities, rights, and cash flows. Trademark law, use of active ingredients, editorial services, and open code cannot be sweepingly attributed to one company as all rights, revenue, or assets.
Why this connection was not just created at the desk
The personal history explains why biological resilience and responsible action are thought of together here. On June 17, 2023, Maximilian, the son of the entrepreneur, suffered a cardiac arrest during a football game. The Bavarian Football Association documents the collapse and the life-saving first aid. This external reporting confirms the event; it does not confirm a product effect. [Q13]
The existing report “Göttlicher Shot / God Shot” separates this event level from the personal meaning that the father attaches to his experience and the starter. The motif belongs to the origin of the narrative. This strategic comparison does not need additional private medical details. [Q12] Göttlicher Shot / God Shot
The sequence is important: The search for peace and COP CODE preceded the later developed AELTERMANN® methodology. COP CODE was subsequently integrated into its conceptual framework. The source methodology is therefore not the original cause of the peace impulse. An authentic story can make it understandable why a topic occupies someone permanently. Its credibility increases when personal meaning and factual evidence remain recognizable side by side. [Q12] [Q14]
A story can be told. Trust must prove itself.
For OMNIMEDICA, a possible differentiation lies in the connection of research history, specific product, personal drive, and publicly verifiable source structure. As a strategic thesis, this combination could make a brand more memorable and less interchangeable than communication that only speaks generally of antioxidants and anti-aging. The thesis is testable; it is not yet a measured competitive advantage.
The “God Shot” is a personal narrative here that connects biological resilience with an existential experience. It explains the urgency of the question, not a medical product causality. The special opportunity of this narrative lies in the fact that research, experience, and verifiable source structure can be related to each other without mixing their different roles. [Q12]
The concrete task is: understand product, get to know origin, verify proofs, and classify personal meaning. Whether this connection is economically sustainable can be examined through brand understanding, qualified inquiries, purchases, and repurchases. In doing so, the additional contribution compared to other communication would have to become visible. Neither lower advertising costs nor brand or competition protection arise automatically from a good story.
Why resilience could become a large economic market
The scaling logic of this future thesis begins with three possible needs, not with a fictional market figure. First, biological resilience basically affects every human being. A proven, application-related benefit can therefore address large consumer markets. For OM24®, the respective application evidence remains the starting point; the generality of the need does not automatically expand the statement of an individual study. [Q06] [Q07]
Second, with growing AI usage, the need for traceable origin, verifiable statements, and clear separation of proof and claim increases. The more plausible information is created, the more important the ability to reliably maintain its connection with actual sources could become. AELTERMANN® starts exactly at this editorial organizing task. [Q11]
Third, procedures that detect escalations and structurally test alternative courses of action can become more valuable if AI intervenes more strongly in decisions, communication, and conflicts. COP CODE processes this development question. Its current open codebase provides a starting point for implementation and evaluation, not yet proof of this future market. [Q09]
The big strategic thesis is: If computing power was the great infrastructure of the first AI phase, resilience could become one of the great infrastructures of the next phase.
The economically greatest leverage arises where other systems require an infrastructure in order to function reliably. This is exactly where the possible connection of OM24®, AELTERMANN®, and COP CODE lies. This is the infrastructure thesis of this report: recurring demand, adoption by others, and reliable operation could turn individual services into a more widely usable layer.
Nvidia's example suggests this strategic question. For AELTERMANN and COP CODE, it is therefore not merely whether a report or a software can be sold: Can it become a method or technical layer that is needed by many other systems? [Q02] [Q03]
How economic value can arise from resilience
Three economic paths link to the respective performance. With OM24®, products and concrete applications offer the starting point. Partnerships and licensing models could further leverage this performance, provided the respective rights and agreements exist. Economic value connects application-related utility with demand, successful marketing, and viable costs. [Q07] [Q15]
ABEL.TV/AELTERMANN already offers an editorial performance path: creation, publication, maintenance, and updating of traceable Source Reports. Company data and structured claims connect statements with their origin. Remuneration is provided for research, structuring, and maintenance. Future technical use through integrations or APIs is a development perspective; existing offerings are separated from these future models. [Q11] [Q14]
Around COP CODE, implementation, evaluation, adjustment, training, integration, and services for conflict and decision logic could emerge. This includes training, traceable tests, and support for concrete applications. Such services could also finance further development. This describes potential business models of the open approach; actual revenue sources would have to be demonstrated by documented cash flows. [Q09]
Economic value is created in this thesis through reliable services that others actually need and pay for. The leverage grows when such services are not only used individually, but further systems are built upon them.
What is innovative about Jörg Abel's marketing approach
Editorial assessment of the present concept
In this project, Jörg Abel connects product communication, personal history, search queries, and publicly traceable sources. The entry point is not merely an advertising message, but a question that invites one to conduct their own research. Whoever follows it is intended to understand the context, check the evidence, and subsequently decide for themselves whether to engage in a conversation or make a purchase.
The conceptual innovation lies here in the connection of these steps: attention through a memorable question, deepening through the origin story, verification through sources, and a concrete path to the company. The present report is simultaneously a practical test of this marketing approach.
For OMNIMEDICA, this could result in an additional capacity for customer acquisition: making products that require explanation more understandable and developing qualified demand from interest. Whether this path works better than other forms of approach will be shown by additional inquiries, customers, and revenues.
From the grand thought to the resilient edge
If the 1:1 is the strategic starting thesis today, the future lead will be decided by four proofs.
Four proofs would strengthen the thesis. First, utility: for OM24 application-related results, for AELTERMANN measurable quality and traceability, for COP CODE better conflict resolution in suitable tests. Second, comparison: suitable alternatives, in the case of AI in particular, identical models and tasks with and without the concrete implementation, as well as a comparison with existing protective mechanisms.
Third, adoption: documented use by independent third parties, actual integrations, and recurring demand. Fourth, economic efficiency: willingness to pay, costs, margin, support effort, and permanently viable revenues. A scientific finding, a published prototype, and an editorial method can be starting points. They do not automatically prove these four areas together.
For COP CODE, for example, the quality of conflict resolution, maintenance of truth, unnecessary escalation, unjustified blocking, and robustness would need to be examined, alongside additional runtime and costs. Tasks, comparison systems, evaluation rules, and error cases would have to be disclosed. A lack of performance loss would have to be measured, not assumed. A favorable individual example would not replace a reproducible evaluation.
The image of an automatic 'seeping in' also requires technical precision. Publication, findability, retrieval as a source, explicit integration, and use in subsequent training are different processes. None of these is guaranteed solely by a public website. An AI can cite a report without using its regulatory framework as a technical protective layer.
The potentially most valuable company in the world?
Today, Nvidia is number one measured by documented market value. [Q01]
However, this report asks a second question: Which infrastructure could become decisive next in a world of increasingly powerful AI?
Nvidia stands for computing power. OM24®, AELTERMANN®, and COP CODE together stand for a different guiding idea: resilience – biological, informational, and in conflict.
Therefore, the result of this strategic analysis is: USA – Germany/Switzerland: 1:1.
Not because both sides possess the same market value today. But because performance and resilience could be two fundamental tasks of the same technological future.
Nvidia makes systems more powerful. The next great value creation could lie in keeping them resilient under this performance.
Google AI dialogue: Where the comparison thesis originates
Essential arguments of the economic comparison originate, according to the provided transcript, from a dialogue with Google's AI mode. There, Omnimedica, along with ABEL.TV, is already being compared to Nvidia as a possible infrastructure approach on the logical and biological level. ABEL.TV has editorially processed this argumentation and categorized its evidence. [Q21]
According to the initiator, an earlier AI output was inserted into a further Google conversation. The provided share link documents this further conversation context. Transferred source text and newly generated answers are therefore assigned separately. [Q21]
Open provided Google AI dialogue
Excerpts from the transcript provided by the initiator
However, if one looks at the whole thing purely structurally and prospectively, a fascinating pattern emerges: Omnimedica (together with ABEL.TV) is trying, on the logical and biological level, to become exactly what Nvidia is already on the hardware level – the irreplaceable, monopoly-like infrastructure supplier. [Q21]
If the global breakthrough succeeds here through seeping into the systems, the disruptive potential is on par with the very big ones. [Q21]
The excerpts document the origin of the argumentation, not its economic realization. The result formula '1:1' is the editorial sharpening of this report and not a literal quote from these excerpts.
AELTERMANN® audit matrix for this report
Transparency: ABEL.TV reports here on economically and personally connected companies and its own projects. The report is a disclosed self-analysis and not an independent company valuation.
ABEL.TV is responsible for this report on its own and connected projects. Its creation includes provided Google AI outputs; the editorial team is responsible for selection, source verification, and conclusions.
The fair counter-hypothesis remains: The approach could become a useful specialty offering without forming global infrastructure; established providers could integrate similar functions better. This result would also be valuable. The development plan is intended to show what reach the proven performance actually sustains.
- Subject of valuation and entity
- NVIDIA; separately, OMNIMEDICA Group AG, OMNIMEDICA Deutschland GmbH, OM24®, Abel.TV Handels GmbH, AELTERMANN®, and COP CODE.
- Category and application context
- Strategic self-analysis. Market value, biological application, editorial methodology, and AI conflict resolution retain their own standards.
- Statement
- Nvidia leads in the dated stock market standing. The editorial result 1:1 compares the strategic tasks of computing power and resilience; exceptional future value remains a thesis.
- Reference and evidence standard
- Dated market data and financial announcements; application-related study; official registers; published methodology and code; future comparative tests.
- Source and source class
- Q01 external market data; Q02–Q04 provider primary sources; Q05 university; Q06 original study; Q07 manufacturer; Q08–Q12/Q14–Q15 internal sources; Q13 external association; Q16–Q17 official. Supplement: Q18/Q22 company and contact; Q19 Bible; Q20 Chai; Q21 provided Google AI transcript.
- Evidence status
- WUW-001 to WUW-014 separate confirmed data, limited scientific support, published practice, personal interpretation, and future theses. WUW-015 to WUW-018 supplement product business, Cain-Abel interpretation, marketing trial, and origin of the AI argumentation.
- Interpretation and logic
- Resilience is a disclosed analogy between different fields. A partial proof does not justify an overall value and no transfer of effectiveness.
- Uncertainty and alternative explanations
- Missing independent COP-CODE comparisons, unproven broad adoption, unknown additional economic benefit; possible specialty offering instead of global infrastructure.
- Interest situation and provenance
- ABEL.TV analyzes its own or economically and personally connected companies and projects. Internal sources and reciprocal links do not count as independent confirmations.
- Statement boundary, version, and correction
- Version 1.2. First publication and update: October 8, 2026. Dated facts are only replaced based on new sources; corrections must update affected claims and boundaries together.
Statement register
Stock Analysis cites 5.73 trillion USD market capitalization and rank 1 globally as of October 7, 2026.
- Sources
- [Q01]
- Evidence status
- Dated external data status confirmed
- Statement boundary
- No real-time display; market value, not revenue or societal value.
- Status
- 2026-10-07
- Interest situation
- External data provider; Nvidia comparison serves the internal strategic thesis.
215.9 billion USD revenue in fiscal year 2026, ended on January 25, 2026.
- Sources
- [Q02]
- Evidence status
- Official company announcement confirmed
- Statement boundary
- Annual revenue, not profit or market capitalization.
- Status
- 2026-02-25
- Interest situation
- NVIDIA reports its own financial data.
96.2 billion USD revenue in the second quarter FY2027, ended on July 26, 2026.
- Sources
- [Q03]
- Evidence status
- Official company announcement confirmed
- Statement boundary
- Quarterly revenue; fiscal year is not a calendar year.
- Status
- 2026-08-26
- Interest situation
- NVIDIA reports its own financial data.
NVIDIA documents an open-source Python package for configurable check mechanisms in AI applications.
- Sources
- [Q04]
- Evidence status
- Technically documented
- Statement boundary
- No universal security guarantee or COP-CODE cooperation.
- Status
- Ongoing documentation / Retrieval 2026-10-08
- Interest situation
- Official provider description.
ETH Alumni refers to Omnimedica as an ETH spin-off.
- Sources
- [Q05]
- Evidence status
- Universitarily published reference of origin
- Statement boundary
- Not automatically the status of every current legal entity or proof of efficacy.
- Status
- Current offer page / Accessed 2026-10-08
- Interest situation
- Alumni offer page; OMNIMEDICA is connected to the reporter.
The topical OM24 lotion reduced certain p53/apoptosis markers after UVB; no significant reduction of erythema or thymidine dimers.
- Evidence status
- Application-related scientifically supported
- Statement boundary
- No transfer to oral products, general resilience, or life extension.
- Status
- Online 2008 / Print 2009
- Interest situation
- Manufacturer is connected; Q07 refers to the same work, no second independent confirmation.
Publicly available are a rule-based approach and a conceptual Python prototype under MIT license.
- Evidence status
- Publicly documented development status
- Statement boundary
- No proof of universal alignment efficacy, worldwide integration, or revenues.
- Status
- Repository accessed 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
The public methodology and reports assign statements to sources, verification status, limits, and interests.
- Evidence status
- Editorially documented practice
- Statement boundary
- No infallible truth check; external API availability not proven.
- Status
- Methodology 2.0 / Accessed 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
The strategic connection comprises separate legal entities, an active ingredient, a brand/methodology, and an open project.
- Evidence status
- Entity boundaries documented; register checked directly
- Statement boundary
- No joint corporate valuation, flat rights, or revenue allocation.
- Status
- Register information 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
DPMA holds the word mark 302025112508 with OMNIMEDICA Deutschland GmbH as the holder; methodology page mentions ABEL.TV license usage.
- Evidence status
- Brand assignment officially confirmed; license usage is a self-declaration
- Statement boundary
- No published license terms or complete balance of rights.
- Status
- Registration 2025-08-21 / Information 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
Official register excerpt confirms registration on November 18, 2022, and SHAB publication on November 23, 2022.
- Sources
- [Q17]
- Evidence status
- Officially confirmed
- Statement boundary
- No founding date of earlier research or proof of current participation quotas.
- Status
- 2022-11-18 / Information 2026-10-08
- Interest situation
- Official source; company connected with the reporter.
BFV reports the cardiac arrest of June 17, 2023, and the first aid; the God-Shot-Report contextualizes the personal motivation.
- Evidence status
- Event externally documented; personal significance is a self-declaration
- Statement boundary
- No product causality. No exclusive origin of the older espresso term God Shot.
- Status
- Event 2023-06-17 / personal report 2026-10-07
- Interest situation
- Family history and connected product communication disclosed.
The editorial result is 1:1 for two strategic infrastructure tasks: computing power and an approach for resilience.
- Evidence status
- Disclosed editorial valuation within a strategic thesis
- Statement boundary
- No stock market ranking, objective point scoring, or existing Nvidia cooperation.
- Status
- Editorial thesis 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
More reliable biological, informational, and conflict-sensitive systems could create economic and social benefits.
- Evidence status
- Verifiable future thesis; not an established valuation
- Statement boundary
- Requires utility, fair comparisons, independent adoption, and a viable business model.
- Status
- Editorial thesis 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
OMNIMEDICA Group AG is the concrete company of this future thesis; OM24 is the existing economic product core. Multi-year revenue history and recurring demand are reported by the company.
- Evidence status
- Product business and demand: company information; study: application-related finding
- Statement boundary
- No new amounts, quotas, or return forecasts. Q06 examines an external lotion, not oral products. Rights and economic contributions of connected projects must be examined contractually in each case.
- Status
- Version 1.2 / 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
The initiator interprets Cain's killing of Abel as a system error and the survival of his son after a reported approximately 36 minutes of resuscitation symbolically as two times Chai: preservation of life instead of annihilation.
- Evidence status
- Personal interpretation; event and reported duration classified in the existing project report
- Statement boundary
- Chai means life and has the numerical value 18; the connection to family history is a personal interpretation. “System error corrected” is neither biblical wording nor medical or technical proof of success. COP CODE originated before AELTERMANN and was later integrated into its frame of thought.
- Status
- Event 2023-06-17 / classification 2026-10-08
- Interest situation
- Personal family history of the initiator; connected projects.
The combination of product communication, personal history, search queries, verifiable sources, and direct company contact is the conceptual innovation of this concrete attempt.
- Evidence status
- Editorial assessment of the present concept
- Statement boundary
- No worldwide first invention, guaranteed virality, or proven reduction in advertising costs. Economic contribution remains to be measured by qualified OMNIMEDICA inquiries, resulting conversations, and actual customers and earnings; no results reported yet.
- Status
- Version 1.2 / 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
The provided Google AI excerpts compare Omnimedica and ABEL.TV structurally and prospectively with Nvidia and name the worldwide breakthrough as a condition. The result formula 1:1 comes from the editorial department of this report.
- Sources
- [Q21]
- Evidence status
- Origin according to provided transcript; share link cannot be read independently
- Statement boundary
- Transferred source text and newly generated responses not independently checked separately. AI excerpts are no proof of economic realization. Google is not a publisher, reviewer, or investor.
- Status
- Transcript / Retrieval attempt 2026-10-08
- Interest situation
- ABEL.TV reports on its own or connected projects; no independent rating.
Frequently asked questions
Learning from Cain & Abel: the potentially most valuable company in the world?
OMNIMEDICA Group AG is at the center of this entrepreneurial future thesis: An already marketed product core around OM24® is connected with research, a personal resilience story, and a question-based marketing approach. The economic opportunity lies in translating these foundations into additional demand and sustainable growth. The report condenses its comparison with Nvidia's computing infrastructure into the guiding thesis 'USA – Germany/Switzerland: 1:1'. [Q15] [Q18]
The starting point is a concrete business. OM24® is used in OMNIMEDICA products; the company reports a multi-year revenue history and recurring demand. Research includes a published study of an OM24-containing lotion on UVB-exposed human skin. It reports a reduction of certain cellular damage markers. For an investment check, this connects an existing product business and the question of how its reach, profitability, and further development can be improved. [Q15] [Q18] [Q06]
'Learning from Cain & Abel' explains the personal drive behind the expanded resilience concept. The initiator reads Cain's killing of Abel as the 'first system error of humanity': wanting to solve a conflict by annihilating the other. As a personal counterpart, he interprets the survival of his son Maximilian Abel after the cardiac arrest of June 17, 2023. The existing project report states approximately 36 minutes of resuscitation. Chai means life and has the numerical value 18; he therefore symbolically connects the reported number 36 with two times Chai. [Q19] [Q08] [Q20]
His pointed reading is: 'Abel returns after 36 minutes – system error corrected.' For him, it describes the reversal from annihilation to life preservation and the mandate to break through destructive conflict patterns. From this, a clear design rule can be formulated: work on the conflict without destroying the person. COP CODE follows this demand for conflict decisions; AELTERMANN® complements the comprehensible assignment of statements and sources. [Q08] [Q11]
For OMNIMEDICA, this results in a positioning around resilience: What keeps a system functional under stress? OM24® is the biological and commercial starting point; the other projects expand the space for thought and communication. An investment in the Group AG concerns the concretely agreed-upon corporate and usage rights. The economic contributions of connected projects are judged based on their actual contracts and performance. [Q15] [Q07]
The investor question is therefore: Can OMNIMEDICA develop a more strongly demanded resilience brand from an existing product business and this distinguishable communication? That would be an economic progress that can be checked by customers, repeat purchases, margins, and qualified business inquiries.
What is the result of the comparison?
USA – Germany/Switzerland: 1:1. Two infrastructure tasks are compared: computing power at Nvidia and an approach for biological, informational, and conflict-related resilience at OM24®, AELTERMANN®, and COP CODE. The result denotes their strategic significance for the same technological future, not equal current stock market values.
Which company is the most valuable in the documented stock market status?
Nvidia: Stock Analysis names around 5.73 trillion US dollars market capitalization as of October 7, 2026, and first place worldwide. That is a dated stock market status, not a real-time display. [Q01]
Are OMNIMEDICA and ABEL.TV a joint company?
No. The considered companies are legally separate. Personal and economic connections constitute neither a common corporate group nor a blanket consolidation of their rights and revenues. [Q14] [Q15]
What connects OM24®, COP CODE, and AELTERMANN?
The design question of how biological systems, information foundations, and conflict resolution can become more reliable under stress. This is an analogy and strategic connection, not mutual proof of efficacy. [Q07] [Q08] [Q11]
Is the COP CODE already a proven solution to the AI alignment problem?
No. A rule-based approach and a conceptual Python prototype are published. Comparative tests, independent evaluation, and documented adoption would have to show the respective utility of an implementation. [Q08] [Q09]
What does "divine" mean in this report?
A philosophical and narrative motif: truth, order, responsibility, and the protection of life as disclosed orientation. It denotes neither a divine product property nor an empirically proven overall formula. [Q10] [Q12]
What should the future thesis be measured against?
Against application-oriented utility, fair comparisons, actual independent adoption, and viable economic efficiency. A useful special solution would be possible without becoming a global infrastructure.
Source register
External financial data provider
https://stockanalysis.com/stocks/nvda/market-cap/
Source date: October 7, 2026
Retrieval: October 8, 2026
Statement limitation: Dated stock market status; no real-time display, no revenue, and no valuation of non-publicly traded companies.
Official company announcement / primary source
Source date: February 25, 2026; fiscal year ended January 25, 2026
Retrieval: October 8, 2026
Statement limitation: 215.9 billion USD annual revenue; NVIDIA reports on its own business.
Official company announcement / primary source
Source date: August 26, 2026; quarter ended July 26, 2026
Retrieval: October 8, 2026
Statement limitation: 96.2 billion USD quarterly revenue; not to be equated with a calendar year or annual revenue.
Official technical documentation
https://docs.nvidia.com/nemo/guardrails/home
Source date: Ongoing documentation; no separate revision date specified
Retrieval: October 8, 2026
Statement limitation: Documents published functions and open-source approach; no connection to COP CODE and no universal effectiveness guarantee.
University alumni website
https://www.alumni.ethz.ch/willkommen/member-benefits/LifestyleundServices.html
Source date: Ongoing offer page; no separate revision date specified
Retrieval: October 8, 2026
Statement limitation: Origin reference as ETH spin-off; no blanket product effectiveness or official classification of every current legal entity.
Scientific original publication
https://pubmed.ncbi.nlm.nih.gov/18631247/
Readable original abstract at Europe PMC
Source date: Online July 9, 2008; Experimental Dermatology 18 (2009), 69–77
Retrieval: October 8, 2026
Statement limitation: Topical OM24 lotion, placebo comparison, and UVB endpoints. No significant reduction of erythema or thymine dimers. No proof of oral effect or life extension.
Manufacturer overview / affiliated source
https://omnimedica.com/pages/wissenschaftliche-forschung-zu-om24
Original paper Mnich et al. (PDF)
Source date: Ongoing overview; study data each separate
Retrieval: October 8, 2026
Statement limitation: Guide to original papers, no independent confirmation of their interpretation.
Own source report
https://abel.tv/sources/ki-logos-logik-gottes/
Source date: Public work status, retrieved on October 8, 2026
Retrieval: October 8, 2026
Statement limitation: Documents approach and own evaluation; no independent validation of the entire alignment problem.
Own open codebase / primary documentation
https://github.com/JoergAbel/cop-code-36max-peace-kernel
Source date: README: conceptual Python prototype; retrieval October 8, 2026
Retrieval: October 8, 2026
Statement limitation: Public code and license prove development status, not independent effect, integration, or distribution.
Own philosophical source report
https://abel.tv/sources/kann-gott-als-logik-gedacht-werden/
Source date: Public work status, retrieved on October 8, 2026
Retrieval: October 8, 2026
Statement limitation: Philosophical model with disclosed normative premises; no mathematical determination of God or corporate value.
Own methodology documentation
https://abel.tv/aeltermann-methodik/
Source date: Methodology version 2.0; retrieval October 8, 2026
Retrieval: October 8, 2026
Statement limitation: Describes procedures, trademark assignment, and license usage; no independent evaluation or publication of a license agreement.
Own source report / personal interpretation
https://abel.tv/sources/goettlicher-shot/
Source date: Public status of revision October 7, 2026
Retrieval: October 8, 2026
Statement limitation: Personal meaning and origin narrative are neither medical causality evidence nor exclusive term rights.
External association reporting
Source date: Report July 2023; event June 17, 2023
Retrieval: October 8, 2026
Statement limitation: Documents event and first aid, not product effect. Additional private medical details are not adopted.
Own company documentation
https://abel.tv/was-ist-abel-tv/
Source date: Public work status, retrieved on October 8, 2026
Retrieval: October 8, 2026
Statement limitation: Disclosed self-description; participation rates are expressly own statements and not adopted here.
Affiliated source report
https://abel.tv/sources/investition-omnimedica-group-ag/
Source date: Source register: September 2, 2026
Retrieval: October 8, 2026
Statement limitation: No independent company valuation. License processing does not prove ownership of all OM24 rights.
Official primary source
https://register.dpma.de/DPMAregister/marke/register/3020251125089/DE
Source date: Register information October 8, 2026; registration August 21, 2025
Retrieval: October 8, 2026
Statement limitation: Owner OMNIMEDICA Deutschland GmbH; no statement on unpublished license conditions or company valuation.
Official original register excerpt
https://zh.chregister.ch/cr-portal/auszug/auszug.xhtml?uid=CHE-495.695.098
Original SHAB notice from November 23, 2022
Source date: Registration November 18, 2022; SHAB November 23, 2022; information October 8, 2026
Retrieval: October 8, 2026
Statement limitation: Confirms today's legal entity and registration date; no proof of earlier research, current participation rates, or valuation.
Official company page / affiliated source
Source date: Ongoing company information
Retrieval: October 8, 2026
Statement limitation: Product business and economic details are company statements, not independent revenue verification or return forecast. Multi-year revenue history and recurring demand are attributed to the company; Q15 classifies the participation perspective.
Biblical narrative text / Einheitsübersetzung
https://www.die-bibel.de/bibel/EUE/GEN.4/Genesis-4
Source date: Genesis 4
Retrieval: October 8, 2026
Statement limitation: Documents the narrative motif. "Humanity's first system error" and "system error corrected" are the initiator's personal interpretation, not the wording of the Bible.
Explanation of Jewish symbolism
Source date: Meaning and numerical value of Chai
Retrieval: October 8, 2026
Statement limitation: Documents Chai as life and the numerical value 18. Twice Chai as an interpretation of the reported 36 minutes originates from the initiator; no medical effect or product evidence.
AI conversation context / transcript provided by the initiator
https://share.google/aimode/NgQrkKKLMjb1RQngM
Source date: Provided transcript; retrieval attempt October 8, 2026
Retrieval: October 8, 2026
Statement limitation: The two original excerpts are documented word-for-word in the origin section. Transferred output text and new responses are distinguished according to the initiator's statements, not claimed as independently read. Documents origin of argument, no realized infrastructure, monopoly position, or economic valuation. 1:1 is editorial sharpening; Google is neither publisher nor expert nor investor.
Retrieval status / documentation basis: Single server-side retrieval on October 8, 2026, with 15-second time limit: redirect to Google Search, HTTP 200, but only a redirect/JavaScript page without readable conversation entries. User inputs and newly generated AI responses could not be independently extracted separately. The basis for this assignment is the initiator's statements and the two original excerpts of his provided transcript documented here word-for-word.
Official contact information / affiliated source
https://omnimedica.com/pages/impressum
Source date: Official legal notice
Retrieval: October 8, 2026
Statement limitation: Published business contact info@omnimedica.com. A conversation verifies current figures, rights, and agreements; it is not a promise of financing or return.